Literature DB >> 17950755

Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings.

Takeshi Matsuoka1, Takuya Matsushita, Manabu Osoegawa, Hirofumi Ochi, Yuji Kawano, Futoshi Mihara, Yasumasa Ohyagi, Jun-ichi Kira.   

Abstract

There are two distinct subtypes of multiple sclerosis (MS) in Asians: optic-spinal (OSMS) and conventional (CMS). Longitudinally extensive spinal cord lesions (LESCLs) extending over three or more vertebral segments are characteristic of patients with OSMS, yet in Asians, one-fourth of CMS patients also have LESCLs. To clarify the distinction between LESCLs in OSMS and CMS, and to characterize the relationship between the presence of LESCLs and brain magnetic resonance imaging (MRI) findings, we studied 142 patients with clinically definite MS of relapsing-remitting onset and 12 patients with primary progressive MS (PPMS) by MRI of the whole spinal cord and brain. The former was diagnosed by Poser criteria, including 57 with OSMS, 67 with CMS and 18 with brainstem-spinal form of MS, while the latter by McDonald criteria. The presence of LESCLs throughout the entire clinical course was significantly more common in OSMS patients than in CMS patients, while brain lesions fulfilling the Barkhof criteria (Barkhof brain lesions) were significantly more common in CMS patients than OSMS patients. LESCLs in OSMS patients most frequently affected the upper to middle thoracic cord, with either holocord or central gray matter involvement. By contrast, 70% of LESCLs in CMS patients predominantly affected the peripheral white matter of the mid-cervical cord. LESCLs in patients with PPMS also showed preferential involvement of the peripheral white matter of the mid-cervical cord. One-third of OSMS patients had neither LESCLs nor Barkhof brain lesions more than 10 years after disease onset, and showed significantly milder disability than OSMS patients with LESCLs. These findings suggest that LESCLs are heterogeneous between OSMS and CMS patients, and that there are distinct subtypes of MS in Japanese, according to clinical and MRI findings.

Entities:  

Mesh:

Year:  2007        PMID: 17950755     DOI: 10.1016/j.jns.2007.09.010

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

Review 1.  A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Authors:  Christopher Eckstein; Shiv Saidha; Michael Levy
Journal:  J Neurol       Date:  2011-09-20       Impact factor: 4.849

2.  Spinal cord lesions and disability in Hispanics with multiple sclerosis.

Authors:  L Amezcua; A Lerner; K Ledezma; D Conti; M Law; L Weiner; A Langer-Gould
Journal:  J Neurol       Date:  2013-08-03       Impact factor: 4.849

Review 3.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

4.  Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.

Authors:  Hidenori Ogata; Ryo Yamasaki; Akio Hiwatashi; Nobuyuki Oka; Nobutoshi Kawamura; Dai Matsuse; Motoi Kuwahara; Hidekazu Suzuki; Susumu Kusunoki; Yuichi Fujimoto; Koji Ikezoe; Hitaru Kishida; Fumiaki Tanaka; Takuya Matsushita; Hiroyuki Murai; Jun-Ichi Kira
Journal:  Ann Clin Transl Neurol       Date:  2015-09-11       Impact factor: 4.511

5.  Multiple Sclerosis Patients with Markedly Low Intrathecal Antibody Response in Sri Lanka.

Authors:  S M K Gamage; I Wijeweera; S B Adikari; Katharina Fink; Jan Hillert; Anna Fogdell-Hahn; H M A Sominanda
Journal:  Mult Scler Int       Date:  2018-02-28

6.  Genetic and infectious profiles of Japanese multiple sclerosis patients.

Authors:  Satoshi Yoshimura; Noriko Isobe; Tomomi Yonekawa; Takuya Matsushita; Katsuhisa Masaki; Shinya Sato; Yuji Kawano; Ken Yamamoto; Jun-ichi Kira
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240

7.  Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients.

Authors:  Satoshi Yoshimura; Noriko Isobe; Takuya Matsushita; Katsuhisa Masaki; Shinya Sato; Yuji Kawano; Hirofumi Ochi; Jun-Ichi Kira
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

8.  Poor responses to interferon-beta treatment in patients with neuromyelitis optica and multiple sclerosis with long spinal cord lesions.

Authors:  Kai-Chen Wang; Kuan-Hsiang Lin; Tzu-Chi Lee; Chao-Lin Lee; Shao-Yuan Chen; Shyi-Jou Chen; Li-Te Chin; Ching-Piao Tsai
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.